© 2011 Dannemann Siemsen. Todos os direitos reservados. Biotech IP issues in Brazil Gustavo Morais May 2011 Gustavo Morais May 2011
© 2011 Dannemann Siemsen. Todos os direitos reservados. 2 Brazil - Patents Changing scenario No pharmaceutical and agrochemical patents (products) as of 1945 (processes excluded as of 1969) No provisions concerning living matter TRIPS - Jan 1, 1995 IP Law Nº 9,279 of May 14, 1996 (IPL) No pharmaceutical and agrochemical patents (products) as of 1945 (processes excluded as of 1969) No provisions concerning living matter TRIPS - Jan 1, 1995 IP Law Nº 9,279 of May 14, 1996 (IPL)
© 2011 Dannemann Siemsen. Todos os direitos reservados. 3 Agrochemical patents Patentability of GM microorganisms and of several inventions involving living matter Waive of transition periods Pipeline patents Criteria for damage calculation Agrochemical patents Patentability of GM microorganisms and of several inventions involving living matter Waive of transition periods Pipeline patents Criteria for damage calculation
© 2011 Dannemann Siemsen. Todos os direitos reservados. 4 Preliminary injunctions Civil and criminal penalties against infringers Infringement by equivalency Patent term: 20 years as of filing or 10 years from grant, whichever expires later Problem: ANVISA’s intervention – pharmaceutical products and processes Preliminary injunctions Civil and criminal penalties against infringers Infringement by equivalency Patent term: 20 years as of filing or 10 years from grant, whichever expires later Problem: ANVISA’s intervention – pharmaceutical products and processes
© 2011 Dannemann Siemsen. Todos os direitos reservados. 5 Patentability criteria Novelty Inventive step Industrial applicability Enablement Brazil not a member of Budapest Treaty Biological material may be filed in any IDA Patentability criteria Novelty Inventive step Industrial applicability Enablement Brazil not a member of Budapest Treaty Biological material may be filed in any IDA Patent basics
© 2011 Dannemann Siemsen. Todos os direitos reservados. 6 Patents Subject matter Not patentable : Living beings and parts thereof, including cells even if modified TRIPS 27.3(b) allows exclusion of patentability only “plants and animals” Naturally occurring biological material (even if isolated, purified or synthesized) and natural biologic processes
© 2011 Dannemann Siemsen. Todos os direitos reservados. 7 Not patentable : Therapeutic, surgical and diagnostic methods applied to human or animal bodies Discoveries as opposed to inventions Genetic Use Restriction Technologies (GURTs) Crime to use, sell, register, patent and license Not patentable : Therapeutic, surgical and diagnostic methods applied to human or animal bodies Discoveries as opposed to inventions Genetic Use Restriction Technologies (GURTs) Crime to use, sell, register, patent and license
© 2011 Dannemann Siemsen. Todos os direitos reservados. 8 Patentable: Microorganisms genetically modified through human intervention Modified DNA/RNA sequences and genes Considered as chemical compounds Any process of genome modification Patentable: Microorganisms genetically modified through human intervention Modified DNA/RNA sequences and genes Considered as chemical compounds Any process of genome modification
© 2011 Dannemann Siemsen. Todos os direitos reservados. 9 Patentable: Chemical compositions characterized by its intrinsic features, even if including naturally occurring biological material Processes for obtaining, isolating, modifying, manufacturing and using biological materials and living beings Except humans (biosafety law) Patentable: Chemical compositions characterized by its intrinsic features, even if including naturally occurring biological material Processes for obtaining, isolating, modifying, manufacturing and using biological materials and living beings Except humans (biosafety law)
© 2011 Dannemann Siemsen. Todos os direitos reservados. 10 Polynucleotides e polypeptides Allowable claims: DNA sequence characterized by presenting... Sequence DNA sequence characterized by being Seq. ID nº Recombinant protein characterized by being Seq. ID nº Not allowable claims: DNA sequence characterized by codifying protein X Protein characterized by presenting activity Y Allowable claims: DNA sequence characterized by presenting... Sequence DNA sequence characterized by being Seq. ID nº Recombinant protein characterized by being Seq. ID nº Not allowable claims: DNA sequence characterized by codifying protein X Protein characterized by presenting activity Y
© 2011 Dannemann Siemsen. Todos os direitos reservados. 11 Polynucleotides e polypeptides Naturally occuring biological material – not patentable A composition including such material may be if its only distinctive feature is not the presence of of the material Purifying and isolation methods - patentable Naturally occuring biological material – not patentable A composition including such material may be if its only distinctive feature is not the presence of of the material Purifying and isolation methods - patentable
© 2011 Dannemann Siemsen. Todos os direitos reservados. 12 Antibodies Patentable Monoclonal antibody characterized by its hybridoma Not patentable Polyclonal antibodies since they considered a by-product of natural biological processes Patentable Monoclonal antibody characterized by its hybridoma Not patentable Polyclonal antibodies since they considered a by-product of natural biological processes
© 2011 Dannemann Siemsen. Todos os direitos reservados. 13 Methods of treatment and diagnosis Not patentable per se Swiss type claims Patentable - methods of obtaining data outside the human or animal body such as measuring blood pressure, X-ray examination, hemograms, etc. Not patentable - methods of diagnosis performed in the human or animal body (e.g, to determine an allergy) Not patentable per se Swiss type claims Patentable - methods of obtaining data outside the human or animal body such as measuring blood pressure, X-ray examination, hemograms, etc. Not patentable - methods of diagnosis performed in the human or animal body (e.g, to determine an allergy)
© 2011 Dannemann Siemsen. Todos os direitos reservados. 14 Stem cells Not patentable per se Patentable - methods of obtaining stem cells and using them, except if method of treatment or diagnosis Not patentable per se Patentable - methods of obtaining stem cells and using them, except if method of treatment or diagnosis
© 2011 Dannemann Siemsen. Todos os direitos reservados. 15 IP in agriculture Plants not patentable, even if GM Only the genes Plant variety protection Examples of allowable claims: Method of pest or weed control using certain agrochemicals and/or plants Process to confer to plants resistance to XYZ pesticide Plants not patentable, even if GM Only the genes Plant variety protection Examples of allowable claims: Method of pest or weed control using certain agrochemicals and/or plants Process to confer to plants resistance to XYZ pesticide
© 2011 Dannemann Siemsen. Todos os direitos reservados. 16 Access to Brazilian biodiversity Authorization to access GRs and associated TK Indication of source in patent applications filed as of 2007 Components of genetic heritage x biological resources Recent PTO office actions and fines imposed on companies Authorization to access GRs and associated TK Indication of source in patent applications filed as of 2007 Components of genetic heritage x biological resources Recent PTO office actions and fines imposed on companies
© 2011 Dannemann Siemsen. Todos os direitos reservados. Thank you! Obrigado!